The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| KRMD | +58.52% | +10.03% | +1.93% | +10,600% |
| S&P | +20.12% | +68.19% | +10.95% | +1,918% |
KORU Medical Systems, Inc. engages in the design, manufacture, and market of proprietary medical devices. Its product portfolio includes FREEDOM60, FreedomEdge syringe drivers, Precision Flow Rate Tubing, and HIgH-Flo Subcutaneous Safety Needle Sets. The company was founded by Andrew I. Sealfon and Adrian W. Zorgniotti on March 24, 1980 and is headquartered in Mahwah, NJ.
| Q4 2025 | YOY Change | |
|---|---|---|
| Revenue | $10.90M | 23.3% |
| Gross Profit | $6.64M | 24.0% |
| Gross Margin | 60.93% | 0.4% |
| Market Cap | $269.13M | 52.5% |
| Market Cap / Employee | $3.69M | 0.0% |
| Employees | 73 | -8.7% |
| Net Income | -$486.86K | 68.8% |
| EBITDA | -$367.93K | 73.3% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q4 2025 | YOY Change | |
|---|---|---|
| Net Cash | $8.87M | -7.4% |
| Accounts Receivable | $6.21M | 8.6% |
| Inventory | 3.7 | 31.2% |
| Q4 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $2.96M | -7.7% |
| Short Term Debt | $538.36K | -31.6% |
| Q4 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -9.09% | 12.2% |
| Return On Invested Capital | -25.57% | -7.0% |
| Q4 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $686.97K | -30.1% |
| Operating Free Cash Flow | $1.09M | 16.5% |
| Metric | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | 6.94 | 10.11 | 10.72 | 16.34 | 64.16% |
| Price to Sales | 5.25 | 3.33 | 4.49 | 4.53 | 15.85% |
| Price to Tangible Book Value | 7.26 | 10.57 | 11.19 | 17.04 | 64.04% |
| Enterprise Value to EBITDA | -166.55 | -1083.64 | -242.44 | -468.31 | 435.08% |
| Return on Equity | -29.9% | -25.6% | -21.7% | -15.6% | -52.27% |
| Total Debt | $3.73M | $3.47M | $3.67M | $3.50M | -12.37% |
No podcast episodes available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
